Methotrexate sodium inj
This code is not in the latest file (4Q26). It was last listed in 1Q24.
Payment limit per 5 MG, by effective quarter, 1Q21 to 1Q24. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.This code is not in the latest file (4Q26). It was last listed in 1Q24.
Payment limit per 5 MG, by effective quarter, 1Q21 to 1Q24. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.No NDCs mapped to this code in the 4Q26 crosswalk.
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 1Q24 | $0.307 | +$0.074 | 5 MG | Methotrexate sodium inj | v1, posted December 19, 2024 |
| 4Q23 | $0.233 | −$0.041 | 5 MG | Methotrexate sodium inj | v1, posted October 10, 2024 |
| 3Q23 | $0.274 | +$0.029 | 5 MG | Methotrexate sodium inj | v1, posted June 5, 2024 |
| 2Q23 | $0.245 | +$0.026 | 5 MG | Methotrexate sodium inj | v1, posted February 23, 2024 |
| 1Q23 | $0.219 | −$0.043 | 5 MG | Methotrexate sodium inj | v1, posted December 6, 2023 |
| 4Q22 | $0.262 | +$0.065 | 5 MG | Methotrexate sodium inj | v1, posted June 22, 2023 |
| 3Q22 | $0.197 | −$0.039 | 5 MG | Methotrexate sodium inj | v1, posted June 9, 2023 |
| 2Q22 | $0.236 | +$0.029 | 5 MG | Methotrexate sodium inj | v1, posted December 14, 2022 |
| 1Q22 | $0.207 | −$0.009 | 5 MG | Methotrexate sodium inj | v1, posted June 8, 2022 |
| 4Q21 | $0.216 | −$0.007 | 5 MG | Methotrexate sodium inj | v1, posted June 2, 2022 |
| 3Q21 | $0.223 | +$0.012 | 5 MG | Methotrexate sodium inj | v1, posted June 2, 2022 |
| 2Q21 | $0.211 | +$0.001 | 5 MG | Methotrexate sodium inj | v1, posted March 1, 2022 |
| 1Q21 | $0.21 | – | 5 MG | Methotrexate sodium inj | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.